KING FAISAL SPECIALIST HOSPITAL & RESEARCH CENTER

πŸ‡ΈπŸ‡¦Saudi Arabia
Ownership
-
Employees
-
Market Cap
-
Website

The Combination of GnRh Analogue and Aromatase Inhibitor in Receptor Positive Premenopausal Women With Advanced Breast Cancer

First Posted Date
2011-03-09
Last Posted Date
2011-12-13
Lead Sponsor
King Faisal Specialist Hospital & Research Center
Target Recruit Count
2
Registration Number
NCT01311037
Locations
πŸ‡ΈπŸ‡¦

Kfsh & Rc, Riyadh, Saudi Arabia

Magnitude of Changes in 25 OH Vitamin D3 Levels After Vitamin D3 Supplementation

First Posted Date
2010-07-27
Last Posted Date
2018-03-07
Lead Sponsor
King Faisal Specialist Hospital & Research Center
Registration Number
NCT01170507
Locations
πŸ‡ΈπŸ‡¦

King Faisal Specialist Hospital & Research Center, Riyadh, Saudi Arabia

Does Vitamin D Reduce Risk of Developing Type II DM in High Risk Individuals

Phase 3
Terminated
Conditions
Interventions
First Posted Date
2010-07-27
Last Posted Date
2018-03-07
Lead Sponsor
King Faisal Specialist Hospital & Research Center
Target Recruit Count
25
Registration Number
NCT01170468
Locations
πŸ‡ΈπŸ‡¦

King Faisal Specialist Hospital & Research Center, Riyadh, Saudi Arabia

Does Vitamin D Improve Glycemic Control in Type II DM?

First Posted Date
2010-07-27
Last Posted Date
2015-04-01
Lead Sponsor
King Faisal Specialist Hospital & Research Center
Target Recruit Count
25
Registration Number
NCT01170442
Locations
πŸ‡ΈπŸ‡¦

King Faisal Specialist Hospital & Research Center, Riyadh, Saudi Arabia

Phase III Trial of High Dose vs. Standard Dose Vit D2 With Docetaxel in Met Breast ca

First Posted Date
2009-07-23
Last Posted Date
2011-12-13
Lead Sponsor
King Faisal Specialist Hospital & Research Center
Target Recruit Count
260
Registration Number
NCT00944424
Locations
πŸ‡ΈπŸ‡¦

King Abdulaziz Hospital and Oncology Center, Jeddah, Saudi Arabia

πŸ‡ΈπŸ‡¦

King Fahad Medical City, Riyadh, Saudi Arabia

πŸ‡°πŸ‡Ό

Kuwait Cancer Center, Kuwait City, Kuwait

and more 3 locations

Phase II Pilot Study of Vincristine, Adriamycin, Actinomycin D, Ifosfamide Combination Chemotherapy in Ewing's Sarcoma

Not Applicable
Conditions
First Posted Date
2007-10-10
Last Posted Date
2012-04-17
Lead Sponsor
King Faisal Specialist Hospital & Research Center
Target Recruit Count
10
Registration Number
NCT00541411
Β© Copyright 2024. All Rights Reserved by MedPath